Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylation matters.

J F Costello1, C Plass

  • 1The Brain Tumor Research Center and the Department of Neurological Surgery, University of California, 2340 Sutter, Room N261, San Francisco, San Francisco, CA 94143-0875, USA. jcostello@cc.ucsf.edu

Journal of Medical Genetics
|May 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer.

ESMO open·2025
Same author

Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.

Cancer letters·2019
Same author

Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.

Oncogene·2017
Same author

TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation.

International journal of obesity (2005)·2017
Same author

Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementation.

Human reproduction (Oxford, England)·2016
Same author

IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.

Leukemia·2016
Same journal

Longest surviving patient with a homozygous splice-altering <i>EGFR</i> pathogenic variant presenting with skin autoinflammation and a Bartter-like salt-losing tubulopathy.

Journal of medical genetics·2026
Same journal

Functional characterisation and pathological significance of variants of <i>MEF2C</i> promoter in tetralogy of Fallot.

Journal of medical genetics·2026
Same journal

Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disability.

Journal of medical genetics·2026
Same journal

Inherited retinal disease genes with dual inheritance patterns: insights from the IRD-PT registry.

Journal of medical genetics·2026
Same journal

Interpreting <i>TP53</i> variants: somatic mosaicism and <i>ERCC6L2</i>-driven clonal evolution.

Journal of medical genetics·2026
Same journal

Review of estimates of birth incidence and population prevalence over time and between countries of the rare neurodevelopmental condition Prader-Willi syndrome.

Journal of medical genetics·2026
See all related articles

Genomic methylation patterns are crucial for healthy cells. Aberrant DNA methylation is linked to various diseases, including cancer, and can be detected before clinical symptoms appear.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genomics

Background:

  • Genomic methylation is essential for normal cellular function.
  • Defects in DNA methylation patterns are associated with developmental disorders and cancer.
  • These methylation defects can lead to gene silencing and chromosomal instability, promoting cancer evolution.

Purpose of the Study:

  • To review the current understanding of DNA methylation in normal and diseased states.
  • To explore the role of DNA methylation abnormalities in cancer development and progression.
  • To discuss the implications of methylomics in cancer research and clinical applications.

Main Methods:

  • Review of existing literature on DNA methylation.
  • Analysis of methylomics data integrating genetic alterations in tumors.

Related Experiment Videos

  • Discussion of diagnostic and prognostic potential of methylation biomarkers.

    • Main Results:

    • Methylation defects are present early in cancer development, preceding clinical detection.
    • Aberrant DNA methylation is linked to tumor response to chemotherapy and patient survival.
    • Methylomics reveals a higher prevalence of methylation abnormalities than previously expected.

    Conclusions:

    • DNA methylation plays a critical role in both normal physiology and disease pathogenesis.
    • Methylomics provides a comprehensive view of methylation abnormalities in cancer.
    • Understanding DNA methylation is key to developing novel cancer diagnostics and therapeutics.